These include injecting just under the skins surface in the stomach, upper arm or thigh, ideally into fat
Average weight loss in GLP-1 trials (top maintenance dose) Source Average total body-weight loss at the top maintenance dose in pivotal trials (SCALE, STEP, SURMOUNT, phase-2 retatrutide)
Recent work suggested that the reduction in both food intake and body weight observed in response to combined treatment with GLP-1RAs and PYY 3-36 results in synergistically-enhanced activation of discrete hypothalamic and brainstem circuits that regulate appetite, including the arcuate nucleus (ARC), the paraventricular nuclei of the hypothalamus (PVNs), the central nucleus of the amygdala (CeA), and the hindbrain (AP/NTS) 10,12,21,44
10.1016/j.phymed.2023.155165 53 KaganV
Gut Elimination: Making Sure Estrogen Leaves the Body Calcium D-glucarate bridges Phase II and gut elimination